Aaron Gentzler is the publisher of Seven Figure Publishing. He is also the editor of The Rundown and has been with Agora Financial / Seven Figure Publishing since 2005. He's been covering technology and markets for over a decade.
Two weeks ago, Silicon Valley company DoorDash filed with the SEC to go public under the ticker DASH sometime before the end of the year.
While there’s a lot of hype surrounding the Dow’s 30,000 milestone… small-cap stocks lead recoveries.
The two pharmaceutical companies that appear to be pulling ahead in the race for a COVID-19 vaccine -- Pfizer and Moderna -- share some unique challenges.
Elon Musk tweets he “most likely” has COVID-19, but we believe Musk’s tweets are a set up for a more significant revelation…
An unparalleled number of Americans voted by mail in 2020 because of the pandemic. But does voting by mail (VBM) increase voter fraud?
“The big ‘COVID push’ has sent biotech stocks to all-time highs,” says Greg Guenthner.
The market responds to Pfizer’s vaccine news, and some kicked-to-the-curb stocks get some love.
“If we’ve learned anything [this year],” says Ray Blanco, “it’s that tech stocks can survive nearly anything that’s thrown their way.